AURX Nuo Therapeutics, Inc.

Fundamentals / CIK 0001091596 / USD

Nuo Therapeutics, Inc. reported $6.03M in revenue and a net loss of $1.90M for the trailing twelve months ended September 30, 2026 (up 80.8% year over year), with a 64.6% gross margin and a -26.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AURX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2015 to 2025), reported in USD.

$16.92M$8.46M$0-$50.35MFY 2015 Revenue: $11.51MFY 2015 Net Income: -$52.81M2015FY 2017 Revenue: $721KFY 2017 Net Income: -$14.98M2017FY 2018 Revenue: $1.37MFY 2018 Net Income: -$1.54M2018FY 2019 Revenue: $146KFY 2019 Net Income: -$1.19M2019FY 2020 Revenue: $0FY 2020 Net Income: -$91K2020FY 2021 Revenue: $0FY 2021 Net Income: -$91K2021FY 2022 Revenue: $112KFY 2022 Net Income: -$3.17M2022FY 2023 Revenue: $609KFY 2023 Net Income: -$3.17M2023FY 2024 Revenue: $1.37MFY 2024 Net Income: -$2.32M2024FY 2025 Revenue: $3.31MFY 2025 Net Income: -$2.51M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $3.31M $1.37M $609K $112K $0 $0 $146K $1.37M $721K $11.51M
Cost of Revenue $1.10M $303K $126K $19K $0 $0 $115K $163K $1.09M $7.97M
Gross Profit $2.22M $1.06M $482K $93K $0 $0 $32K $1.21M -$370K $3.54M
Research & Development -- -- -- -- $0 $0 $181K $576K $1.33M $2.55M
Selling, General & Admin $4.73M $3.52M $3.65M $3.41M $91K $378K $820K $2.14M $4.54M $15.26M
Total Operating Expenses $4.73M $3.52M $3.65M $3.41M $91K $378K $1.00M $2.71M $15.16M $44.86M
Operating Income -$2.52M -$2.46M -$3.17M -$3.32M -$91K -$378K -$969K -$1.50M -$15.53M -$41.32M
EBITDA -$2.43M -$2.43M -$3.15M -$3.31M -$91K -$378K -$879K -$1.40M -$14.42M -$40.58M
Interest Income -- -- -- -- -- -- -- -- -- $28K
Interest Expense -- -- -- -- $0 $48K $221K $39K $11K $39.31M
Income Before Tax -$2.51M -$2.32M -$3.17M -$3.17M -$91K -$91K -$1.19M -$1.54M -$14.98M -$52.90M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 -- -- -$89K
Net Income -$2.51M -$2.32M -$3.17M -$3.17M -$91K -$91K -$1.19M -$1.54M -$14.98M -$52.81M
Basic EPS -$0.05 -$0.05 -$0.08 -$0.08 -$0.03 $0.30 -$0.05 -$0.07 -$1.02 -$0.42
Diluted EPS -- -- -- -- -$0.03 $0.27 -$0.05 -$0.07 -$1.02 -$0.42
Basic Shares Outstanding 47.3M 45.4M 42.1M 40.0M 30.3M 25.7M 23.7M 23.3M 14.6M 126.0M
Diluted Shares Outstanding -- -- -- -- 30.3M 27.3M 23.7M 23.3M 14.6M 126.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.87M $1.77M $1.30M $1.10M $1.03M $700K $484K $395K
Cost of Revenue $673K $599K $452K $408K $407K $159K $121K $86K
Gross Profit $1.19M $1.17M $850K $688K $625K $541K $363K $308K
Selling, General & Admin $1.57M $1.34M $1.30M $1.27M $1.17M $1.19M $1.11M $938K
Total Operating Expenses $1.57M $1.34M $1.30M $1.27M $1.17M $1.19M $1.11M $938K
Operating Income -$374K -$167K -$446K -$579K -$540K -$652K -$745K -$629K
EBITDA -$374K -$140K -$424K -$555K -$517K -$629K -$730K -$618K
Net Income -$425K -$278K -$618K -$578K -$538K -$650K -$746K -$497K
Basic EPS -$0.01 -$0.01 -$0.01 -- -$0.01 -$0.01 -$0.02 --
Basic Shares Outstanding 48.5M 48.4M 48.3M -- 47.5M 46.8M 46.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Sep 30 Jun 30 Mar 31 Dec 31 Sep 30
Cash & Cash Equivalents $549K $284K $929K $2.05M $1.41M $148K $152K $157K $161K $0
Cash & Short-Term Investments $549K $284K $929K $2.05M $1.41M $148K $152K $157K $161K $0
Accounts Receivable, Net $562K $248K $251K $92K $0 -- $0 $0 $0 --
Inventory $214K $150K $210K $240K $0 -- -- -- -- --
Total Current Assets $1.38M $842K $1.56M $2.63M $1.47M $150K $153K $157K $161K $0
Property, Plant & Equipment, Net $366K $177K $45K $53K $0 $0 $0 $0 $0 $0
Total Non-Current Assets $466K $348K $314K $412K $0 $0 $0 $0 $0 $0
Total Assets $1.85M $1.19M $1.88M $3.05M $1.47M $150K $153K $157K $161K $0
Accounts Payable $436K $219K $395K $398K $527K $526K $522K $520K $518K $536K
Deferred Revenue (Current) $300K $0 -- -- -- -- -- -- -- --
Total Current Liabilities $1.31M $578K $675K $600K $673K $672K $669K $667K $665K $1.03M
Long-Term Debt -- -- -- -- $0 -- -- -- -- --
Deferred Revenue (Non-Current) $975K $0 -- -- -- -- -- -- -- --
Total Non-Current Liabilities $1.50M $97K $164K $256K $0 $0 $0 $0 $0 $0
Total Liabilities $2.80M $676K $839K $856K $673K $672K $669K $667K $665K $1.03M
Total Debt (incl. Leases) $97K $164K $256K $335K $0 -- -- -- -- --
Common Stock $4.8K $4.7K $4.4K $4.2K $3.7K $3.0K $3.0K $3.0K $3.0K $2.4K
Retained Earnings -$34.77M -$32.26M -$29.94M -$26.76M -$23.59M -$23.52M -$23.51M -$23.51M -$23.50M -$23.27M
Total Stockholders' Equity -$957K $514K $1.04M $2.19M $793K -$523K -$516K -$509K -$504K -$1.03M
Total Equity -$957K $514K $1.04M $2.19M $793K -$523K -$516K -$509K -$504K -$1.03M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $81K $449K $264K $549K $515K $316K $56K $284K
Cash & Short-Term Investments $81K $449K $264K $549K $515K $316K $56K $284K
Accounts Receivable, Net $1.41M $1.17M $874K $562K $652K $320K $277K $248K
Inventory $330K $270K $249K $214K $202K $166K $99K $150K
Total Current Assets $1.98M $1.99M $1.52M $1.38M $1.46M $853K $602K $842K
Property, Plant & Equipment, Net $705K $572K $345K $366K $347K $370K $392K $177K
Total Non-Current Assets $746K $633K $425K $466K $465K $506K $545K $348K
Total Assets $2.73M $2.63M $1.95M $1.85M $1.93M $1.36M $1.15M $1.19M
Accounts Payable $757K $563K $385K $436K $492K $313K $662K $219K
Deferred Revenue (Current) $381K $312K $312K $300K $300K $300K $200K $0
Total Current Liabilities $2.45M $1.55M $1.37M $1.31M $1.26M $999K $1.28M $578K
Deferred Revenue (Non-Current) $952K $857K $935K $975K $1.05M $1.12M -- $0
Total Non-Current Liabilities $2.12M $2.61M $1.96M $1.50M $1.09M $1.19M $79K $97K
Total Liabilities $4.58M $4.16M $3.33M $2.80M $2.35M $2.18M $1.36M $676K
Total Debt (incl. Leases) $41K $60K $79K $97K $115K $132K $148K $164K
Common Stock $4.9K $4.8K $4.8K $4.8K $4.8K $4.7K $4.7K $4.7K
Retained Earnings -$36.09M -$35.67M -$35.39M -$34.77M -$34.19M -$33.66M -$33.01M -$32.26M
Total Stockholders' Equity -$1.85M -$1.54M -$1.38M -$957K -$420K -$825K -$213K $514K
Total Equity -$1.85M -$1.54M -$1.38M -$957K -$420K -$825K -$213K $514K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$2.51M -$2.32M -$3.17M -$3.17M -$91K -$91K -$1.19M -$1.54M -$14.98M -$52.81M
Depreciation & Amortization $85K $23K $15K $6.8K $0 $0 $90K $102K $1.11M $741K
Stock-Based Compensation $86K $57K $22K $9.1K $14K $334K $50K $7.1K $54K $783K
Change in Receivables -$405K -$77K -$318K -$92K $0 $0 $22K -- -- --
Change in Inventory -$83K $29K $14K -$240K $0 $0 $25K -$5.3K $19K $272K
Change in Payables $217K -$42K -$3.2K $18K $8.1K -$30K $101K $57K -$12K -$811K
Operating Cash Flow -$865K -$2.23M -$3.17M -$3.71M -$120K -$54K -$922K -$874K -$4.90M -$14.39M
Capital Expenditure -$275K -$155K -$7.2K -$60K $0 $0 $0 -- -- -$698K
Free Cash Flow -$1.14M -$2.39M -$3.18M -$3.77M -$120K -$54K -$922K -- -- -$15.09M
Investing Cash Flow -$275K -$155K -$7.2K -$60K $0 $0 $0 $2.0K $1.9K -$629K
Common Stock Issued $791K $1.50M $2.00M -- $0 $195K $0 $500K $2.92M $0
Share Repurchases -- -- -- -- -- -- -- -- -$471 --
Financing Cash Flow $1.40M $1.74M $2.00M $4.46M $1.37M $195K $305K $816K $2.92M $0
Net Change in Cash $265K -$645K -$1.18M $692K $1.25M $141K -$617K -$57K -$1.98M -$15.02M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$425K -$278K -$618K -$578K -$538K -$650K -$746K -$497K
Depreciation & Amortization $612 $26K $22K $24K $23K $23K $15K $12K
Stock-Based Compensation $89K $41K $24K $24K $20K $23K $19K $30K
Change in Receivables -$322K -$294K -$312K $41K -$361K -$44K -$41K $19K
Change in Inventory -$61K -$21K -$35K -$22K -$36K -$67K $42K $17K
Change in Payables $194K $178K -$51K -$56K $179K -$349K $443K -$33K
Operating Cash Flow -$195K -$236K -$784K -$423K -$707K $262K $1.8K -$491K
Capital Expenditure -$174K -$253K -$847 -$43K $0 -$1.7K -$230K $0
Free Cash Flow -$368K -$490K -$785K -$466K -$707K $261K -$228K -$491K
Investing Cash Flow -$174K -$253K -$847 -$43K $0 -$1.7K -$230K $0
Financing Cash Flow $0 $675K $500K $500K $905K $0 $0 $90K
Net Change in Cash -$368K $185K -$285K $34K $198K $261K -$228K -$400K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 66.9% 77.8% 79.3% 82.9% -- -- 21.6% 88.1% -51.3% 30.8%
Operating Margin -76.0% -180.0% -520.6% -2958.2% -- -- -663.0% -109.8% -2154.4% -359.0%
Net Profit Margin -75.8% -170.2% -521.2% -2825.6% -- -- -817.4% -112.5% -2077.4% -458.8%
Return on Equity (ROE) -- -452.3% -305.2% -144.7% -11.4% -- -- -- -3102.0% --
Return on Assets (ROA) -136.1% -195.4% -168.9% -104.1% -6.2% -56.3% -432.1% -158.1% -1051.8% -746.5%
Current Ratio 1.06x 1.45x 2.32x 4.39x 2.18x 0.24x 0.19x 0.82x 1.27x 0.07x
Quick Ratio 0.89x 1.19x 2.01x 3.99x 2.18x 0.24x 0.01x 0.80x 1.23x 0.07x
Debt to Equity -- 0.32x 0.25x 0.15x 0.00x -- -- -- 0.00x --
Revenue Growth (YoY) +142.7% +124.3% +442.1% -- -- -100.0% -89.3% +90.1% -- +48.3%
Gross Profit Growth (YoY) +108.8% +120.2% +418.5% -- -- -100.0% -97.4% -- -- +257.5%
EPS Growth (YoY) -- -- -- -- -110.0% -- -- -- -- --
5Y Revenue / Share Growth -- +387.7% -75.4% -94.3% -- -100.0% -90.4% -47.3% -61.9% --
10Y Revenue / Share Growth -23.4% -53.3% -87.0% -97.8% -100.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 64.6% 64.1% 65.5% 66.9% 70.4% 76.0% 76.9% 77.8%
Operating Margin -26.0% -33.3% -53.7% -76.0% -98.3% -133.5% -154.4% -180.0%
Net Profit Margin -31.5% -38.7% -57.7% -75.8% -93.1% -126.7% -146.2% -170.2%
Return on Equity (ROE) -- -- -- -- -- -- -- -452.3%
Return on Assets (ROA) -69.6% -76.6% -122.6% -136.1% -126.1% -181.7% -205.9% -195.4%
Current Ratio 0.81x 1.28x 1.11x 1.06x 1.16x 0.85x 0.47x 1.45x
Quick Ratio 0.67x 1.11x 0.93x 0.89x 1.00x 0.69x 0.39x 1.19x
Debt to Equity -- -- -- -- -- -- -- 0.32x
Revenue Growth (YoY) +80.8% +152.6% +168.8% +177.8% +178.2% +92.0% +106.5% +100.4%
Gross Profit Growth (YoY) +90.7% +116.3% +133.9% +123.2% +131.2% +80.6% +97.5% +98.2%
Operating Cash Flow Growth (YoY) -- -190.1% -43073.8% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -287.8% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001091596) · from June 30, 2010 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal